Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akito Nozaki

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Acta Medica Okayama|May 11, 2002
Quantitative method of intracellular hepatitis C virus RNA using LightCycler PCRAkito Nozaki, Nobuyuki Kato
Case Reports in Gastroenterology|May 31, 2021
A Hepatitis C Virus-Associated Decompensated Cirrhotic Patient Who Showed the Disappearance of Hepatic Encephalopathy, Ascites, and Pleural Effusion by Antiviral Therapy with Sofosbuvir/VelpatasvirKazuo Tarao, Akito Nozaki, Hirokazu Komatsu
Liver International : Official Journal of the International Association for the Study of the Liver|October 3, 2008
Prognosis following non-surgical second treatment in patients with recurrent hepatocellular carcinoma after percutaneous ablation therapyManabu Morimoto, Kazushi Numata, Akito Nozaki, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 24, 2002
[Recent advances of basic research and clinical application of lactoferrin as an antiviral reagent against chronic hepatitis C]Akito Nozaki, Katsuaki Tanaka, Atsushi Naganuma, et al.
Cancer Research|February 20, 2004
Promotion of microsatellite instability by hepatitis C virus core protein in human non-neoplastic hepatocyte cellsAtsushi Naganuma, Hiromichi Dansako, Takashi Nakamura, et al.
World Journal of Hepatology|February 15, 2021
Effectiveness of entecavir in preventing hepatocellular carcinoma development is genotype-dependent in hepatitis B virus-associated liver cirrhosisKazuo Tarao, Akito Nozaki, Makoto Chuma, et al.
Japanese Journal of Clinical Oncology|August 7, 2010
Hepatic arterial infusion therapy with a fine powder formulation of cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosisMasaaki Kondo, Manabu Morimoto, Kazushi Numata, et al.
Modern Rheumatology|September 9, 2011
Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with rheumatoid arthritis treated with methotrexateKeisuke Watanabe, Kaoru Takase, Shigeru Ohno, et al.
Cancer|July 31, 2010
Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolizationManabu Morimoto, Kazushi Numata, Masaaki Kondou, et al.
Virus Research|October 11, 2003
Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response elementHiromichi Dansako, Atsushi Naganuma, Takashi Nakamura, et al.
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Acta Medica Okayama|May 11, 2002
Quantitative method of intracellular hepatitis C virus RNA using LightCycler PCRAkito Nozaki, Nobuyuki Kato
Case Reports in Gastroenterology|May 31, 2021
A Hepatitis C Virus-Associated Decompensated Cirrhotic Patient Who Showed the Disappearance of Hepatic Encephalopathy, Ascites, and Pleural Effusion by Antiviral Therapy with Sofosbuvir/VelpatasvirKazuo Tarao, Akito Nozaki, Hirokazu Komatsu
Liver International : Official Journal of the International Association for the Study of the Liver|October 3, 2008
Prognosis following non-surgical second treatment in patients with recurrent hepatocellular carcinoma after percutaneous ablation therapyManabu Morimoto, Kazushi Numata, Akito Nozaki, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 24, 2002
[Recent advances of basic research and clinical application of lactoferrin as an antiviral reagent against chronic hepatitis C]Akito Nozaki, Katsuaki Tanaka, Atsushi Naganuma, et al.
Cancer Research|February 20, 2004
Promotion of microsatellite instability by hepatitis C virus core protein in human non-neoplastic hepatocyte cellsAtsushi Naganuma, Hiromichi Dansako, Takashi Nakamura, et al.
World Journal of Hepatology|February 15, 2021
Effectiveness of entecavir in preventing hepatocellular carcinoma development is genotype-dependent in hepatitis B virus-associated liver cirrhosisKazuo Tarao, Akito Nozaki, Makoto Chuma, et al.
Japanese Journal of Clinical Oncology|August 7, 2010
Hepatic arterial infusion therapy with a fine powder formulation of cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosisMasaaki Kondo, Manabu Morimoto, Kazushi Numata, et al.
Modern Rheumatology|September 9, 2011
Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with rheumatoid arthritis treated with methotrexateKeisuke Watanabe, Kaoru Takase, Shigeru Ohno, et al.
Cancer|July 31, 2010
Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolizationManabu Morimoto, Kazushi Numata, Masaaki Kondou, et al.
Virus Research|October 11, 2003
Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response elementHiromichi Dansako, Atsushi Naganuma, Takashi Nakamura, et al.
Pageof 12